Cargando…

Prevalence and factors associated with polypharmacy and potential drug interactions in adults in Manaus, Amazonas state, Brazil: a cross-sectional population-based study, 2019

OBJECTIVE: To assess the prevalence and factors associated with polypharmacy and the presence of potential drug interactions in Manaus, Amazonas state, Brazil, in 2019. METHODS: This was a population-based cross-sectional study conducted with adults aged ≥ 18 years. The presence of drug interactions...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiguman, Gustavo Magno Baldin, Biase, Tayanny Margarida Menezes Almeida, Silva, Marcus Tolentino, Galvão, Taís Freire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Secretaria de Vigilância em Saúde - Ministério da Saúde do Brasil 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887957/
https://www.ncbi.nlm.nih.gov/pubmed/35730815
http://dx.doi.org/10.1590/S2237-96222022000200003
_version_ 1784880445404479488
author Tiguman, Gustavo Magno Baldin
Biase, Tayanny Margarida Menezes Almeida
Silva, Marcus Tolentino
Galvão, Taís Freire
author_facet Tiguman, Gustavo Magno Baldin
Biase, Tayanny Margarida Menezes Almeida
Silva, Marcus Tolentino
Galvão, Taís Freire
author_sort Tiguman, Gustavo Magno Baldin
collection PubMed
description OBJECTIVE: To assess the prevalence and factors associated with polypharmacy and the presence of potential drug interactions in Manaus, Amazonas state, Brazil, in 2019. METHODS: This was a population-based cross-sectional study conducted with adults aged ≥ 18 years. The presence of drug interactions among people on a polypharmacy regimen (≥ 5 drugs) was investigated on the Micromedex database. Prevalence ratios (PR) with 95% confidence intervals (95%CI) were calculated using Poisson regression model with robust variance, following hierarchical analysis and considering the complex sample design. RESULTS: Of the 2,321 participants, 2.8% (95%CI 2.1;3.6) were on polypharmacy regimen, of whom, 74.0% presented drug interactions, usually with four or more drug interactions per person (40.4%) and high severity (59.5%). Polypharmacy was higher among older adults (PR = 3.24; 95%CI 1.25;8.42), people with poor health (PR = 2.54; 95%CI 1.14;5.67), previous hospitalization (PR = 1.90; 95%CI 1.09;3.32) and multimorbidity (PR = 3.20; 95%CI 1.53;6.67). CONCLUSION: Polypharmacy was more frequent among older adults and people with medical problems, who presented more drug interactions.
format Online
Article
Text
id pubmed-9887957
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Secretaria de Vigilância em Saúde - Ministério da Saúde do Brasil
record_format MEDLINE/PubMed
spelling pubmed-98879572023-01-31 Prevalence and factors associated with polypharmacy and potential drug interactions in adults in Manaus, Amazonas state, Brazil: a cross-sectional population-based study, 2019 Tiguman, Gustavo Magno Baldin Biase, Tayanny Margarida Menezes Almeida Silva, Marcus Tolentino Galvão, Taís Freire Epidemiol Serv Saude Original Article OBJECTIVE: To assess the prevalence and factors associated with polypharmacy and the presence of potential drug interactions in Manaus, Amazonas state, Brazil, in 2019. METHODS: This was a population-based cross-sectional study conducted with adults aged ≥ 18 years. The presence of drug interactions among people on a polypharmacy regimen (≥ 5 drugs) was investigated on the Micromedex database. Prevalence ratios (PR) with 95% confidence intervals (95%CI) were calculated using Poisson regression model with robust variance, following hierarchical analysis and considering the complex sample design. RESULTS: Of the 2,321 participants, 2.8% (95%CI 2.1;3.6) were on polypharmacy regimen, of whom, 74.0% presented drug interactions, usually with four or more drug interactions per person (40.4%) and high severity (59.5%). Polypharmacy was higher among older adults (PR = 3.24; 95%CI 1.25;8.42), people with poor health (PR = 2.54; 95%CI 1.14;5.67), previous hospitalization (PR = 1.90; 95%CI 1.09;3.32) and multimorbidity (PR = 3.20; 95%CI 1.53;6.67). CONCLUSION: Polypharmacy was more frequent among older adults and people with medical problems, who presented more drug interactions. Secretaria de Vigilância em Saúde - Ministério da Saúde do Brasil 2022-06-15 /pmc/articles/PMC9887957/ /pubmed/35730815 http://dx.doi.org/10.1590/S2237-96222022000200003 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Tiguman, Gustavo Magno Baldin
Biase, Tayanny Margarida Menezes Almeida
Silva, Marcus Tolentino
Galvão, Taís Freire
Prevalence and factors associated with polypharmacy and potential drug interactions in adults in Manaus, Amazonas state, Brazil: a cross-sectional population-based study, 2019
title Prevalence and factors associated with polypharmacy and potential drug interactions in adults in Manaus, Amazonas state, Brazil: a cross-sectional population-based study, 2019
title_full Prevalence and factors associated with polypharmacy and potential drug interactions in adults in Manaus, Amazonas state, Brazil: a cross-sectional population-based study, 2019
title_fullStr Prevalence and factors associated with polypharmacy and potential drug interactions in adults in Manaus, Amazonas state, Brazil: a cross-sectional population-based study, 2019
title_full_unstemmed Prevalence and factors associated with polypharmacy and potential drug interactions in adults in Manaus, Amazonas state, Brazil: a cross-sectional population-based study, 2019
title_short Prevalence and factors associated with polypharmacy and potential drug interactions in adults in Manaus, Amazonas state, Brazil: a cross-sectional population-based study, 2019
title_sort prevalence and factors associated with polypharmacy and potential drug interactions in adults in manaus, amazonas state, brazil: a cross-sectional population-based study, 2019
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887957/
https://www.ncbi.nlm.nih.gov/pubmed/35730815
http://dx.doi.org/10.1590/S2237-96222022000200003
work_keys_str_mv AT tigumangustavomagnobaldin prevalenceandfactorsassociatedwithpolypharmacyandpotentialdruginteractionsinadultsinmanausamazonasstatebrazilacrosssectionalpopulationbasedstudy2019
AT biasetayannymargaridamenezesalmeida prevalenceandfactorsassociatedwithpolypharmacyandpotentialdruginteractionsinadultsinmanausamazonasstatebrazilacrosssectionalpopulationbasedstudy2019
AT silvamarcustolentino prevalenceandfactorsassociatedwithpolypharmacyandpotentialdruginteractionsinadultsinmanausamazonasstatebrazilacrosssectionalpopulationbasedstudy2019
AT galvaotaisfreire prevalenceandfactorsassociatedwithpolypharmacyandpotentialdruginteractionsinadultsinmanausamazonasstatebrazilacrosssectionalpopulationbasedstudy2019